ClinicalTrials.Veeva

Menu

The Use of Smart Glasses for Saphenous Nerve Adductor Canal Block (SMART)

MetroHealth Medical Center logo

MetroHealth Medical Center

Status

Invitation-only

Conditions

Total Knee Arthroplasty

Treatments

Procedure: Smartglasses

Study type

Interventional

Funder types

Other

Identifiers

NCT07213622
STUDY00000465

Details and patient eligibility

About

The use of smart glasses for saphenous nerve adductor canal blocks compared to standard of care.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients 18 years or greater
  • undergoing total knee arthroplasty

Exclusion criteria

  • Patients with local infection at nerve block site
  • BMI >40
  • Patients who are at risk for local anesthesia systemic toxicity due to intraoperative local dose
  • Patients with nerve damage to the femoral or saphenous nerve
  • Documented history of mental or cognitive disabilities in EMR
  • Non-English speaking patient
  • Pregnant Women (self-reported)
  • Prisoners
  • Patients under the age of 18

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Smartglasses
Experimental group
Treatment:
Procedure: Smartglasses
Standard of care
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems